σ-1 selective ligand which binds with high affinity to human malignant melanoma cells A 2058.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 358.22. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.79 mL||13.96 mL||27.92 mL|
|5 mM||0.56 mL||2.79 mL||5.58 mL|
|10 mM||0.28 mL||1.4 mL||2.79 mL|
|50 mM||0.06 mL||0.28 mL||0.56 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
John et al (1994) [125I]N-(2-Piperidinylaminoethyl)-4-iodobenzamide and related analogues as sigma receptor imaging agents; high affinity binding to human malignant melanoma and rat C6 glioma cell lines. J.Labelled Comp.Radiopharm. 35 242 PMID:
If you know of a relevant reference for N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide, please let us know.
View Related Products by Product Action
Keywords: σ1 sigma1 selective ligand Receptors IPAB Sigma1 Receptors
Citations for N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide
Citations are publications that use Tocris products.
Currently there are no citations for N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide. Do you know of a great paper that uses N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide from Tocris? If so please let us know.
Literature in this Area
New Product Guide (Spring/Summer 2017)New
Our new product guide highlights over 130 new products added to the Tocris Bioscience range during the first half of 2017.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Cell Metabolism
- Fluorescent Imaging
- Signal Transduction
- Stem Cells